UBS Group’s Morphic Holding, Inc. Common Stock MORF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-41,460
| Closed | -$1.41M | – | 10402 |
|
|
2024
Q2 | $1.41M | Sell |
41,460
-107,534
| -72% | -$3.19M | ﹤0.01% | 4101 |
|
|
2024
Q1 | $5.24M | Buy |
148,994
+56,441
| +61% | +$1.89M | ﹤0.01% | 2922 |
|
|
2023
Q4 | $2.67M | Buy |
92,553
+48,404
| +110% | +$1.15M | ﹤0.01% | 3504 |
|
|
2023
Q3 | $1.01M | Buy |
44,149
+25,666
| +139% | +$1.35M | ﹤0.01% | 4063 |
|
|
2023
Q2 | $1.06M | Buy |
18,483
+17,979
| +3,567% | +$939K | ﹤0.01% | 4187 |
|
|
2023
Q1 | $19K | Sell |
504
-13,641
| -96% | -$503K | ﹤0.01% | 7120 |
|
|
2022
Q4 | $378K | Buy |
+14,145
| New | +$387K | ﹤0.01% | 4937 |
|
|
2022
Q2 | – | Sell |
-1,353
| Closed | -$54K | – | 11162 |
|
|
2022
Q1 | $54K | Buy |
+1,353
| New | +$56.6K | ﹤0.01% | 6426 |
|
|
2021
Q4 | – | Sell |
-27,819
| Closed | -$1.58M | – | 10871 |
|
|
2021
Q3 | $1.58M | Buy |
27,819
+25,348
| +1,026% | +$1.53M | ﹤0.01% | 3793 |
|
|
2021
Q2 | $142K | Buy |
2,471
+1,802
| +269% | +$99.1K | ﹤0.01% | 5613 |
|
|
2021
Q1 | $42K | Sell |
669
-2,202
| -77% | -$101K | ﹤0.01% | 6732 |
|
|
2020
Q4 | $96K | Sell |
2,871
-7,922
| -73% | -$234K | ﹤0.01% | 5716 |
|
|
2020
Q3 | $295K | Buy |
10,793
+6,490
| +151% | +$170K | ﹤0.01% | 4560 |
|
|
2020
Q2 | $116K | Sell |
4,303
-2,366
| -35% | -$44.3K | ﹤0.01% | 5187 |
|
|
2020
Q1 | $98K | Sell |
6,669
-1,633
| -20% | -$27.4K | ﹤0.01% | 5317 |
|
|
2019
Q4 | $142K | Buy |
8,302
+2,977
| +56% | +$46.4K | ﹤0.01% | 5820 |
|
|
2019
Q3 | $96K | Buy |
5,325
+5,122
| +2,523% | +$107K | ﹤0.01% | 5788 |
|
|
2019
Q2 | $4K | Buy |
+203
| New | +$3.84K | ﹤0.01% | 7470 |
|
Other funds holding MORF
UBS Group's MORF Position: Q3 2024 in Review
UBS Group sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 41,460 shares — an estimated $1.41M sold.
UBS Group first reported a position in MORF in Q2 2019 and held it in 18 quarters. The position peaked at $5.24M in Q1 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.
- UBS Group reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- UBS Group sold 41,460 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $1.41M.
- UBS Group first reported a position in Morphic Holding, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
- UBS Group's Morphic Holding, Inc. Common Stock position peaked at $5.24M in Q1 2024.
- 2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.